Ken Griffin Nephros Inc Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Nephros Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 17,236 shares of NEPH stock, worth $26,715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,236
Previous 11,848
45.48%
Holding current value
$26,715
Previous $24,000
20.83%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NEPH
# of Institutions
18Shares Held
4.28MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.6MShares$5.58 Million1.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA202KShares$313,0900.0% of portfolio
-
Bard Associates Inc Chicago, IL172KShares$267,1750.11% of portfolio
-
Geode Capital Management, LLC Boston, MA85.2KShares$132,1350.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL57.2KShares$88,6750.0% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $16M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...